Free Trial
→ Never thought I’d see this (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$192.81
+0.5%		$181.27
$140.68
▼
$194.48
$464.35B0.48.91 million shs6.34 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$15.20
+1.8%		$18.15
$14.05
▼
$25.17
$29.16B0.7221.00 million shs23.70 million shs
The Best High-Yield Dividend Stocks for 2025 Cover
The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.95%+0.55%+9.07%+13.55%+17.86%
Kenvue Inc. stock logo
KVUE
Kenvue
-0.10%-7.60%-18.51%-33.65%-34.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$192.81
+0.5%		$181.27
$140.68
▼
$194.48
$464.35B0.48.91 million shs6.34 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$15.20
+1.8%		$18.15
$14.05
▼
$25.17
$29.16B0.7221.00 million shs23.70 million shs
The Best High-Yield Dividend Stocks for 2025 Cover
The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.95%+0.55%+9.07%+13.55%+17.86%
Kenvue Inc. stock logo
KVUE
Kenvue
-0.10%-7.60%-18.51%-33.65%-34.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.77
Moderate Buy$199.053.24% Upside
Kenvue Inc. stock logo
KVUE
Kenvue
2.38
Hold$21.1839.38% Upside

Current Analyst Ratings Breakdown

Latest JNJ and KVUE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/22/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Johnson Rice
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Price TargetOutperform ➝ Hold$190.00
10/22/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Price Target$190.00
10/20/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Daiwa America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		UpgradeHold ➝ Strong-Buy
10/20/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Daiwa Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		UpgradeNeutral ➝ Outperform$203.00
10/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetBuy$210.00 ➝ $215.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Price Target$210.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetOutperform$174.00 ➝ $209.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Price Target$190.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetHold$165.00 ➝ $190.00
10/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Price TargetBuy$213.00 ➝ $215.00
10/14/2025
Kenvue Inc. stock logo
KVUE
Kenvue
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated RatingHold (C-)
(Data available from 10/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B5.23$13.06 per share14.76$29.69 per share6.49
Kenvue Inc. stock logo
KVUE
Kenvue
$15.14B1.93$1.49 per share10.17$5.04 per share3.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$10.3618.6117.422.2827.26%33.08%13.30%N/A
Kenvue Inc. stock logo
KVUE
Kenvue
$1.03B$0.7420.5312.252.159.37%20.06%7.78%11/6/2025 (Estimated)

Latest JNJ and KVUE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/6/2025Q3 2025
Kenvue Inc. stock logo
KVUE
Kenvue
$0.27N/AN/AN/A$3.83 billionN/A
10/14/2025Q3 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.76$2.80+$0.04$2.12$23.73 billion$23.99 billion
8/7/2025Q2 2025
Kenvue Inc. stock logo
KVUE
Kenvue
$0.28$0.29+$0.01$0.22$3.94 billion$3.84 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.202.70%N/A50.19%64 Years
Kenvue Inc. stock logo
KVUE
Kenvue
$0.835.46%N/A112.16%1 Years

Latest JNJ and KVUE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/14/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.302.72%11/25/202511/25/202512/9/2025
7/30/2025
Kenvue Inc. stock logo
KVUE
Kenvue
quarterly$0.20753.74%8/13/20258/13/20258/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.50
1.01
0.76
Kenvue Inc. stock logo
KVUE
Kenvue
0.66
0.98
0.68

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Kenvue Inc. stock logo
KVUE
Kenvue
97.64%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Kenvue Inc. stock logo
KVUE
Kenvue
0.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Kenvue Inc. stock logo
KVUE
Kenvue
22,0001.92 billion1.92 billionOptionable

Recent News About These Companies

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
 |  msn.comhttps://www.msn.com/en-us/news/other/tylenol-maker-kenvue-s-stock-is-down-30-in-2025-its-fate-may-be-in-the-fda-s-hands/ar-AA1OZOa6
This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?
 |  msn.comhttps://www.msn.com/en-us/money/top-stocks/this-billionaire-investor-is-thrilled-to-own-kenvue-stock-despite-tylenol-turbulence-should-you-buy-kvue-here/ar-AA1OZzrJ
Nordea Investment Management AB Has $3.47 Million Position in Kenvue Inc. $KVUE
October 22 at 4:21 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nordea-investment-management-ab-has-347-million-position-in-kenvue-inc-kvue-2025-10-22/
Kenvue Inc. (KVUE): A Bull Case Theory
October 22 at 2:16 AM  |  msn.comhttps://www.msn.com/en-us/news/other/kenvue-inc-kvue-a-bull-case-theory/ar-AA1OVDAB
Kenvue Inc. (KVUE): A Bull Case Theory 
October 21 at 10:51 PM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/kenvue-inc-kvue-a-bull-case-theory-1620964/
Starboard’s Smith says Kenvue exploring all alternatives
October 21 at 3:15 PM  |  msn.comhttps://www.msn.com/en-us/news/other/starboard-s-smith-says-kenvue-exploring-all-alternatives/ar-AA1OUgTl
Moderately bullish activity in Kenvue Inc with shares up 0.1%
October 21 at 3:15 PM  |  msn.comhttps://www.msn.com/en-us/news/other/moderately-bullish-activity-in-kenvue-inc-with-shares-up-01/ar-AA1OU5yf
Starboard's Jeff Smith 'thrilled to own' Kenvue at current valuation
October 21 at 3:15 PM  |  msn.comhttps://www.msn.com/en-us/news/other/starboards-jeff-smith-thrilled-to-own-kenvue-at-current-valuation/ar-AA1OUcoU
Starboard Value CEO: We're thrilled to own Kenvue at this valuation
October 21 at 12:01 PM  |  youtube.comY
Kenvue Inc. (NYSE:KVUE) Leads Consumer Stocks in S&P 500 Today
October 21 at 10:14 AM  |  kalkinemedia.comK
Beech Hill Advisors Inc. Has $1.84 Million Position in Kenvue Inc. $KVUE
October 21 at 7:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-beech-hill-advisors-inc-has-184-million-position-in-kenvue-inc-kvue-2025-10-21/
Divergent Planning LLC Takes Position in Kenvue Inc. $KVUE
October 21 at 6:24 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-divergent-planning-llc-takes-position-in-kenvue-inc-kvue-2025-10-21/
Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Brokerages
October 21 at 5:47 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/kenvue-inc-nysekvue-receives-consensus-rating-of-hold-from-brokerages-2025-10-21/
Kenvue urges US FDA to reject request for Tylenol's autism warning
October 21 at 5:12 AM  |  msn.comhttps://www.msn.com/en-us/health/other/kenvue-urges-us-fda-to-reject-request-for-tylenols-autism-warning/ar-AA1OQ3Bs
Kenvue asks FDA to not change Tylenol label on potential autism risk
October 21 at 5:12 AM  |  msn.comhttps://www.msn.com/en-us/health/other/kenvue-asks-fda-to-not-change-tylenol-label-on-potential-autism-risk/ar-AA1OQ5G4
Kenvue at the Cross-Road
October 21 at 5:12 AM  |  finance.yahoo.comhttps://finance.yahoo.com/news/kenvue-cross-road-112424856.html
Kenvue urges US FDA to deny request for Tylenol's autism warning
October 20 at 12:35 PM  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/kenvue-urges-us-fda-deny-request-tylenols-autism-warning-2025-10-20/
Meet the 5%-Yielding Dividend Stock That Could Soar in 2026
October 19 at 1:25 PM  |  fool.comhttps://www.fool.com/investing/2025/10/19/meet-the-3-yielding-dividend-stock-that-could-soar/
Kenvue Inc. $KVUE Position Cut by Parthenon LLC
October 19 at 6:57 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-kenvue-inc-kvue-position-cut-by-parthenon-llc-2025-10-19/
TrueMark Investments LLC Buys 18,623 Shares of Kenvue Inc. $KVUE
October 19 at 5:37 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-truemark-investments-llc-buys-18623-shares-of-kenvue-inc-kvue-2025-10-19/
Kenvue (NYSE:KVUE) Trading Up 8.6% - Still a Buy?
October 18, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/kenvue-nysekvue-trading-up-86-still-a-buy-2025-10-17/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
SoundHound on cellphone
SoundHound Breaks Critical Resistance: How High Can It Get Now?
By Thomas Hughes | September 28, 2025
Dollar bills and fall leaves
October’s Top 5 Stocks Poised for Big Breakouts
By Thomas Hughes | October 1, 2025
Big Pharma, health care, pharmaceutical industry and medical business vintage news and newspaper printing. Abstract concept retro headlines 3d illustration. — Photo
Why AbbVie and Johnson & Johnson Could Outperform Pfizer
By Chris Markoch | October 8, 2025
JNJ on cellphone
Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off
By Thomas Hughes | October 15, 2025
Johnson and Johnson logo seen on a smartphone screen with stock trading
Johnson & Johnson's M&A Strategy Is the Real Story for Investors
By Jeffrey Neal Johnson | October 18, 2025
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$192.81 +0.93 (+0.48%)
Closing price 03:59 PM Eastern
Extended Trading
$192.55 -0.26 (-0.13%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Kenvue stock logo

Kenvue NYSE:KVUE

$15.20 +0.27 (+1.77%)
Closing price 03:59 PM Eastern
Extended Trading
$15.30 +0.11 (+0.72%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas